Roivant Sciences
ROIV
147 hedge funds and large institutions have $3.39B invested in Roivant Sciences in 2023 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 57 increasing their positions, 19 reducing their positions, and 13 closing their positions.
300% more call options, than puts
Call options by funds: $4.77M | Put options by funds: $1.19M
292% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 13
200% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 19
34% more funds holding
Funds holding: 110 → 147 (+37)
3.8% more ownership
Funds ownership: 56.78% → 60.57% (+3.8%)
3% more capital invested
Capital invested by funds: $3.29B → $3.39B (+$100M)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$99M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$48.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$38.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$33.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$98.8M |
| 2 |
HH
HSG Holding
Na,
Hong Kong
|
-$10.8M |
| 3 |
PT
Palantir Technologies
Denver,
Colorado
|
-$9.59M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$9.43M |
| 5 |
WCM
Whitefort Capital Management
New York
|
-$4.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
D.E. Shaw & Co
New York
| – | -$1M | -125,530 | Closed |
|
|
FFA
152
Farther Finance Advisors
San Francisco,
California
| – | -$535K | -67,008 | Closed |
|
|
SAM
153
Shell Asset Management
The Hague,
Netherlands
| – | -$196K | -24,534 | Closed |
|
|
QT
154
Quantamental Technologies
White Plains,
New York
| – | -$168K | -21,007 | Closed |
|
|
XT
155
XTX Topco
George Town,
Cayman Islands
| – | -$161K | -20,205 | Closed |
|
156
HighTower Advisors
Chicago,
Illinois
| – | -$146K | -18,200 | Closed |
|
157
HSBC Holdings
London,
United Kingdom
| – | -$92.6K | -11,834 | Closed |
|
158
Rockefeller Capital Management
New York
| – | -$23K | -3,000 | Closed |
|
|
WAM
159
Wolverine Asset Management
Chicago,
Illinois
| – | -$6.57K | -822 | Closed |
|
160
CI Investments Inc
Toronto,
Ontario, Canada
| – | +$156 | +19 | New |
|
ROIV Hedge Fund Activity: Q1 2023 in Review
147 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q1 2023, worth a combined $3.39B — up 3% from $3.29B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new ROIV positions and 13 closed out — a net gain of 38 holders — while 57 added to existing stakes and 19 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $99M. The largest seller was SB Investment Advisers (UK), cutting an estimated $98.8M.
- 147 institutional investors held Roivant Sciences (ROIV) as of Q1 2023, up from 110 in Q4 2022.
- Funds reported $3.39B of Roivant Sciences stock for Q1 2023, up 3% quarter-over-quarter.
- 51 funds opened new Roivant Sciences positions in Q1 2023 and 13 closed out, a net change of +38 holders.
- The largest Roivant Sciences buyer in Q1 2023 was Wellington Management Group, an estimated $99M added.
- The largest Roivant Sciences seller in Q1 2023 was SB Investment Advisers (UK), an estimated $98.8M sold.
Based on aggregated 13F filings for Q1 2023.